Biofil Chemicals & Pharmaceuticals share news, announcements and annual reports
NSE: BIOFILCHEMBSE: 524396Pharmaceuticals & BiotechnologySmall Cap
Biofil Chemicals & Pharmaceuticals Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 1994 on BSE, Jun 1996 on NSE
Last close ₹28.68down ₹0.73 (2.48%)BSE ₹29.00
Share price at the NSE close on 30 Oct 2026. Previous close ₹29.41.
30 Oct: open ₹29.00, high ₹29.80, low ₹28.26
52-week range of traded prices to 30 Oct 2026
₹25.60Low, 30 Mar 2026₹46.34High, 3 Feb 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹47 Cr3,363rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 96.41
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.16
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 2.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 2.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.14
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,71974.4% delivered
Biofil Chemicals & Pharmaceuticals share news and announcements
403 announcements, routine notices left out, newest first. Page 6 of 9.
Feb 2019
4 Feb · Board meeting
Nov 2018
14 Nov · Results
Sep 2018
27 Sep · Meeting
Aug 2018
13 Aug · Management
13 Aug · Board meeting
13 Aug · Board meeting
13 Aug · Board meeting
13 Aug · Results
6 Aug · Board meeting
May 2018
30 May · Results
30 May · Board meeting
23 May · Board meeting
Apr 2018
Feb 2018
12 Feb · Board meeting
12 Feb · Results
Nov 2017
15 Nov · Results
Sep 2017
26 Sep · Management
25 Sep · Management
Aug 2017
7 Aug · Legal
Exchange has sought clarification from Biofil Chemicals & Pharmaceuticals Limited with respect to announcement dated 04-Aug-2017, regarding "Outcome of Board Meeting held on August 04, 2017." On basis of above the Company is required to clarify following: 1. Brief profile (in case of appointment);The response of the Company is awaited.4 Aug · Results
4 Aug · Board meeting
Jul 2017
19 Jul · Revocation of Suspension of Securities
Members of the Exchange are hereby notified that the suspension in trading of the securities of Biofil Chemicals & Pharmaceuticals Limited will be revoked w.e.f. July 27, 2016 on account of satisfactory redressal of issues of non-compliance of the erstwhile Listing Agreement and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
May 2017
30 May · Results
Apr 2017
Mar 2017
20 Mar · Public Notice - Compulsory Delisting
Members of the Exchange are hereby informed that the Exchange on February 25, 2017 has issued public notice in the newspaper for proposed compulsory delisting of equity shares of the company, in term of Regulation 22 (3) of SEBI (Delisting of Equity shares) Regulation, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/common/CorporateAnnouncements).
Feb 2017
9 Feb · Results
Jan 2017
Nov 2016
14 Nov · Results